Financhill
Sell
38

BCYC Quote, Financials, Valuation and Earnings

Last price:
$8.03
Seasonality move :
9.16%
Day range:
$8.09 - $8.80
52-week range:
$6.10 - $28.67
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
20.44x
P/B ratio:
0.76x
Volume:
378.7K
Avg. volume:
430.5K
1-year change:
-64.07%
Market cap:
$561.6M
Revenue:
$35.3M
EPS (TTM):
-$3.14

Earnings Data

Next earnings date for BCYC
Aug 06
2025
Most recent earnings per share
-$0.88
Missed by $0.07
(May 1/2025)
Consensus Estimate
-$0.81
(May 1/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BCYC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/06/2025 Q2 $9.4M -- -- -$0.93 --
05/01/2025 Q1 $8.7M $10M -$0.88 -$0.81 -$0.07
02/25/2025 Q4 $5.5M $3.7M -$0.75 -$0.85 $0.10
10/31/2024 Q3 $7M $2.7M -$0.74 -$0.78 $0.04
08/06/2024 Q2 $6.3M $9.4M -$0.77 -$1.11 $0.34
05/02/2024 Q1 $6.1M $19.5M -$0.62 -$1.21 $0.59
02/20/2024 Q4 $7M $5.3M -$1.16 -$1.19 $0.03
11/02/2023 Q3 -- -- -$1.26 -$1.06 -$0.20
08/03/2023 Q2 -- -- -$1.41 -$1.07 -$0.34
05/04/2023 Q1 -- -- -$1.30 -$0.96 -$0.34
02/28/2023 Q4 -- -- -$1.01 -$1.04 $0.03
11/03/2022 Q3 -- -- -$0.96 -$0.91 -$0.05
08/04/2022 Q2 -- -- -$0.90 -$0.81 -$0.09
05/05/2022 Q1 -- -- -$0.93 -$0.73 -$0.21
03/01/2022 Q4 -- -- -$0.63 -$0.59 -$0.04
11/04/2021 Q3 -- -- -$0.59 -$0.63 $0.04
08/05/2021 Q2 -- -- -$0.74 -$0.67 -$0.07
05/06/2021 Q1 -- -- -$0.73 -$0.71 -$0.02
03/11/2021 Q4 -- -- -$0.83 -$0.41 -$0.42
11/05/2020 Q3 -- -- -$0.52 -$0.53 $0.01
08/05/2020 Q2 -- -- -$0.67 -$0.46 -$0.21
05/07/2020 Q1 -- -- -$0.63 -$0.38 -$0.25
03/10/2020 Q4 -- -- -$0.25 -$0.52 $0.27
11/07/2019 Q3 -- -- -$0.53 -$0.70 $0.17
08/08/2019 Q2 -- -- -$1.40 -$0.62 -$0.78
03/31/2019 Q1 -- -- -$0.37 -- --
12/31/2018 Q4 -- -- -$0.50 -- --
09/30/2018 Q3 -- -- -$0.58 -- --
06/30/2018 Q2 -- -- -$0.37 -- --
03/31/2018 Q1 -- -- -$0.19 -- --

Bicycle Therapeutics PLC Earnings Questions

  • How Much did Bicycle Therapeutics PLC Generate in Revenue Last Quarter?

    Bicycle Therapeutics PLC reported $10M worth of top line sales in its most recent quarter.

  • Did Bicycle Therapeutics PLC Beat Earnings Last Quarter?

    Bicycle Therapeutics PLC announced earnings per share of -$0.88 which represents a miss of analyst forecast a -$0.81 per share.

  • Is Bicycle Therapeutics PLC Profitable?

    Bicycle Therapeutics PLC reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Bicycle Therapeutics PLC EPS Next Year?

    Bicycle Therapeutics PLC's earnings are forecast to decrease from -$2.90 per share to -$3.05 per share next year representing a decrease of -31.59%.

  • When is Bicycle Therapeutics PLC's Earnings Date?

    Bicycle Therapeutics PLC's next earnings date is August 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Which Stocks Are Recession-Proof?
Which Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Is Gartner a Safe Stock to Own?
Is Gartner a Safe Stock to Own?

Gartner (NYSE:IT) is among the world’s largest consulting, research and…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 44x

Alerts

Buy
57
RGC alert for May 14

Regencell Bioscience Holdings [RGC] is up 8.9% over the past day.

Buy
54
HALO alert for May 14

Halozyme Therapeutics [HALO] is down 4.72% over the past day.

Buy
91
COIN alert for May 14

Coinbase Global [COIN] is up 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock